Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1546, Issue 2, 2001, Pages 337-345

  Chuang, Victor Tuan Giam ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Benzodiazepine; Binding site; Fatty acid; Flunitrazepam; Human serum albumin; Photoaffinity labeling

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DANSYL CHLORIDE; DANSYLSARCOSINE; DIAZEPAM; FLUDIAZEPAM; FLUNITRAZEPAM; HUMAN SERUM ALBUMIN; INDOLE; LIGAND; MEDAZEPAM; MYRISTIC ACID; NIMETAZEPAM; NITRAZEPAM; OROSOMUCOID; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CONCENTRATION RESPONSE; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN DOMAIN; REACTION ANALYSIS;

ANTI-ANXIETY AGENTS; AUTORADIOGRAPHY; BENZODIAZEPINES; BINDING SITES; BINDING, COMPETITIVE; DIAZEPAM; FLUNITRAZEPAM; FLUORESCENT DYES; HUMANS; LIGANDS; MYRISTIC ACID; OROSOMUCOID; PHOTOAFFINITY LABELS; SERUM ALBUMIN;

EID: 0035820385     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(01)00151-0     Document Type: Article

References (51)

1. Molecular aspects of ligand binding to serum albumin
2. Structure and ligand binding properties of human serum albumin
3. Structure of serum albumin
4. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites
5. Fatty acid binding to human serum albumin: New insights from crystallographic studies
6. Crystal structure of human serum albumin at 2.5 Å resolution
7. The characterization of two specific drug binding sites on human serum albumin
8. Further characterization of specific drug binding sites on human serum albumin
9. High-affinity binding of ethacrynic acid is mediated by the two most important drug binding sites of human serum albumin
10. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone
11. Benzodiazepines: Specific competitors for the binding of l-tryptophan to human serum albumin
12. Binding of drugs to human serum albumin. XI. The specificity of three binding sites as studied with albumin immobilized in microparticles
13. Characterization of region Ic in site I on human serum albumin. Microenvironmental analysis using fluorescence spectroscopy
14. Characterization of site I on human serum albumin: Concept about the structure of a drug binding site
15. The in situ acetylation of an immobilized human serum albumin chiral stationary phase for high-performance liquid chromatography in the examination of drug-protein binding phenomenon
16. Location of binding sites on immobilized human serum albumin for some nonsteroidal anti-inflammatory drugs
17. Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: Detection of the allosteric interaction between warfarin and benzodiazepine binding sites
18. Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate
19. Interactive binding to the two principal ligand binding sites of human serum albumin: Effect of the neutral-to-base transition
20. The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties
21. Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatography examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin
22. Stereochemical aspects of benzodiazepine binding to human serum albumin. II. Quantitative relationships between structure and enantioselective retention in high performance liquid affinity chromatography
23. Stereoselective binding of a 2,3-benzodiazepine to human serum albumin. Effect of conformation on tofizopam binding
24. Stereoselective binding of 3-acetoxy-, and 3-hydroxy-1,4-benzodiazepine-2-ones to human serum albumin. Selective allosteric interaction with warfarin enantiomers
25. Direct resolution, characterization, and stereospecific binding properties of an atropisomeric 1,4-benzodiazepine
26. Characterization of the binding of benzodiazepines to human serum albumin
27. The role of substituents in the hydrophobic binding of the 1,4-benzodiazepines by human plasma proteins
28. Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements
29. Brain uptake of benzodiazepines: Effects of lipophilicity and plasma protein binding
30. Photobinding of flunitrazepam and its major photo-decomposition product N-desmethylflunitrazepam
31. Photochemistry of flunitrazepam: A product and model study
32. Deduction of amino acid residues in the GABA(A) receptor alpha subunits photoaffinity labeled with the benzodiazepine flunitrazepam
33. 3H]flunitrazepam is histidine 102 of the alpha subunit
34. 1-acid glycoprotein
35. Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety
36. Photochemical activity of 7-nitro-1,4-benzodiazepines. Formation of singlet molecular oxygen, isolation and identification of decomposition products
37. Photochemical decomposition of 1.4-benzodiazepines. Nitrazepam
38. Relationship between structure and photobiological activity of 7-nitro-1,4-benzodiazepine
39. 3H]flunitrazepam, is a photoaffinity label for the central type of benzodiazepine receptors
40. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin
41. A comparison of drug binding sites on mammalian albumins
42. Binding sites of fluorescent probes on human serum albumin
43. Photoaffinity labeling
44. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin
45. Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin
46. 13C NMR studies of the binding of medium-chain fatty acids to human serum albumin
47. Fatty acid binding to plasma albumin
48. Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin
49. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures